Our study built a prognostic signature on the basis of DNRGs in CRC and obtained six biomarkers, including CHMP2B, TRAF2, RIPK3, CXCL1, GPX4, and CHMP6. This evidence concerns the gene CXCL1 and colorectal carcinoma.